Correspondence  by unknown
peated measures is approximately 3 to 6% (that for peak
VO2 is 8 to 12%). This is particularly important, if no
familiarization exercise test is performed (not reported in
the paper). If the VE/VCO2-slope, nevertheless, is not of
prognostic importance in the patients studied by Osada et
al. this would also be important information.
It is intriguing that in the study of Osada et al. the peak
VO2 was similar in survivors and nonsurvivors, but that the
percentage of predicted peak VO2 was significantly different
(p 5 0.04). It has previously been shown that the skeletal
muscle mass correlates linearly with peak VO2 (r 5 0.68,
p , 0.01) in 100 patients (5). It has been suggested that
obesity is bound to underestimate “true” peak VO2 (6),
whereas in the presence of muscle wasting the peak VO2
rather overestimates “true” exercise capacity (7). When the
survivors and nonsurvivors are not significantly different for
age and sex the main determinant predicting low percentage
predicted peak VO2 is most likely the patients’ low body
weight in relation to ideal body weight. In accordance with
this concept, we have previously shown that the presence of
cardiac cachexia (.7.5% weight loss) or of low ideal body
weight (,85% of ideal) is predictive of mortality in patients
with a peak VO2 #14 ml/kg/min (8).
The VE/VCO2-slope and the presence of cardiac ca-
chexia (or low ideal weight) are simple and useful measure-
ments well recognized in the literature, but unfortunately
have not been discussed by Osada et al. We believe that
without discussion of these available data, Osada et al.’s
important paper is not complete, although, one could argue,
this should have been picked up in the review process.
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We thank Dr. Anker and Dr. Coats for pointing out the
merits of using VE/VCO2-slope as a prognostic predictor of
mortality independent of peak VO2. We did not test
VE/VCO2-slope in relation to peak VO2 as a prognostic
predictor in our report.
There was no significant relationship between body
weight and prognosis. The body weight in the 154 patients
with a peak VO2 ,14 ml/min/kg was 74.2 6 10.7% of ideal
weight. Mortality in patients with ,70% of ideal body
weight was 15% (7/46), 70–85% of ideal weight was 26%
(25/93), and .85% was 20% (3/15) in the 154 patients with
a peak VO2 ,14 ml/min/kg; the differences were not
statistically significant (p 5 0.29).
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